investor login
contact
team
dedicated funds
news
portfolio
Portfolio Company News
Search for:
PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients
Portfolio Company News
AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development
Portfolio Company News
Nature Communications Highlights Research by Scientists at Graybug Vision and Johns Hopkins University on Sustained Treatment of Retinal Diseases
Portfolio Company News
Kymera Therapeutics Announces $102 Million Series C Financing to Advance its Protein Degrader Pipeline and Platform
Portfolio Company News
HealthStream Acquires NurseGrid, #1 Rated and Top Downloaded App for Nurses
Portfolio Company News
Graybug Vision Presents Preclinical Results for GB-401, a Potential Sustained-Delivery Treatment of up to Six Months for Primary Open Angle Glaucoma, at the American Glaucoma Society Annual Meeting
Portfolio Company News
PhaseBio Announces European Regulatory Update for PB2452
Portfolio Company News
Trefoil Therapeutics Appoints Thomas M. Tremblay, RN BSN, Vice President, Clinical Development
Portfolio Company News
PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals® for PB2452
Portfolio Company News
BioSpace.com selects Qpex to be among Top Life Science Companies to Watch in 2020
Portfolio Company News
HistoSonics Robotic Sonic Beam Therapy Platform Wins 2019 Frost & Sullivan Innovation Award
Portfolio Company News
Alkermes to Acquire Rodin Therapeutics
Portfolio Company News
Older Posts >
< Newer Posts
contact
team
dedicated funds
news
home
portfolio
